<p>Russell J. Rackley, Ph.D. Mylan Pharmaceuticals Inc. Vice President, Pharmacokinetics/Drug Metabolism</p><p>Dr. Rackley is Vice President, Pharmacokinetics/Drug Metabolism, North America for Mylan Pharmaceuticals. He holds a BS in Pharmacy and a PhD in Pharmaceutics from the University of Tennessee, Memphis and has over 20 years of Industry experience in pharmaceutical development. His prior work experience includes 7 years as a research scientist at Ciba-Geigy Corporation in the departments of Biopharmaceutics and Clinical Pharmacokinetics; 5 years as Director of Biopharmaceutics at Purepac Pharmaceutical Co.; and the last 11 years at Mylan Pharmaceuticals in Pharmacokinetics/ Drug Metabolism. Areas of expertise include assisting in formulation development with respect to in vitro screening and relevance to in vivo performance, as well as design and reporting of clinical pharmacokinetic and bioequivalency studies. Current responsibilities include serving as a global resource for the development of products to be registered world-wide.</p>